Company news
Olema Pharmaceuticals, Inc. news in 2021
Olema Pharmaceuticals, Inc.'s news releases, calls and decks from 2021, newest first.
Olema Oncology Announces First Clinical Data on OP-1250 in Advanced ER+ / HER2- Breast Cancer
November 29, 2021
Olema Oncology Issues Statement Regarding Falsified Information Circulating on Social Media
November 28, 2021
Olema Oncology to Present New Data on OP-1250 at 2021 San Antonio Breast Cancer Symposium
November 21, 2021
Olema Oncology Reports Third Quarter 2021 Financial Results and Provides Corporate Update
November 9, 2021
Olema Oncology to Present at Two Upcoming Investor Conferences
November 8, 2021
Olema Oncology Announces Trials in Progress Poster on OP-1250 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
September 29, 2021
Olema Oncology to Present Data on OP-1250 at the 2021 JCA-AACR Precision Cancer Medicine International Conference
September 8, 2021
Olema Oncology to Present at Morgan Stanley 19th Annual Global Healthcare Conference
August 29, 2021
Olema Oncology Reports Second Quarter 2021 Financial Results and Provides Corporate Update
August 9, 2021
Olema Oncology to Present at Canaccord Genuity 41st Annual Growth Conference
July 27, 2021
Olema Oncology to Participate at the Jefferies 2021 Virtual Healthcare Conference
May 17, 2021
Olema Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 10, 2021
Olema Oncology Appoints Oncology Biotech Executive Yi Larson, MBA, to Board of Directors
April 5, 2021
Olema Oncology Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Updates
March 16, 2021
Olema Oncology Announces Late-Breaking Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021
March 9, 2021
Olema Oncology to Participate at Upcoming Virtual Investor Conferences
February 22, 2021